High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients

European Journal of Haematology

Volumn 83, Issue 4, 2009, Pages 357-364

  Matsue, Kosei ^a   Aoki, Takatoshi ^a   Odawara, Jun ^a   Fujiwara, Hideaki ^a   Iwama, Kan Ichi ^a   Kimura, Shun Ichi ^a   Yamakura, Masayuki ^a   Takeuch, Masami ^a  

^a Kameda General Hospital   (Japan)

Author keywords

Anti HBc; Entecavir; HBV reactivation; HBV DNA; Hematopoietic cell transplantation

Indexed keywords

BORTEZOMIB; BUSULFAN; CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEXAMETHASONE; ENTECAVIR; ETOPOSIDE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MELPHALAN; METHOTREXATE; RANIMUSTINE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER INJURY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; MYELOMA; NONHODGKIN LYMPHOMA; PLASMAPHERESIS; POEMS SYNDROME; PRIORITY JOURNAL; SEROLOGY; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME; VIRUS REACTIVATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; FEMALE; GUANINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INCIDENCE; LAMIVUDINE; MALE; MIDDLE AGED; PLASMA EXCHANGE; RISK; VIRUS ACTIVATION; YOUNG ADULT;

EID: 70349131938     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01291.x     Document Type: Article

References (26)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008 359 : 1486 1500.
2. Lok AS, Liang RH, Chiu EK, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic chemotherapy: report of a prospective study. Gastroenterology 1991 100 : 182 188.
3. Liang R, Lau GKK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of problem. J Clin Oncol 1999 17 : 394 398.
4. Yeo W, Lam KC, Zee B, et al. Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Ann Oncol 2004 15 : 1661 1666. (Pubitemid 39562607)
5. Dhedin N, Douvin C, Kuentz M, et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pre-transplant anti-HBs and anti-HBc. Transplantation, 1998 66 : 616 619.
6. Seth P, Alrajhi AA, Kagevi I, Chaudhary MA, Colcol E, Sahovic E, Aljurf M, Gyger M. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 2002 30 : 189 194.
7. Onozawa M, Hashino S, Izumiyama K, et al. Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection. Transplantation 2005 79 : 616 619.
8. Kempinska A, Kwak E, Angel JB. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis 2005 41 : 1277 1282.
9. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat 2007 14 : 478 483.
10. Chopra R, McMillan AK, Linch DC, Yuklea S, Taghipour G, Pearce R, Patterson KG, Goldstone AH. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients. Blood 1993 81 : 1137 1145.
11. Sasaki M, Matsue K, Takeuchi M, Mitome M, Hirose Y. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation. Int J Hematol 2000 71 : 75 8.
12. Kamisango K, Kamogawa C, Sumi M, Goto S, Hirao A, Gonzales F, Yasuda K, Iino S. Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay. J Clin Microbiol 1999 37 : 310 314. (Pubitemid 29056395)
13. Weinberger KM, Wiedenmann E, Böhm S, Jilg W. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system(TaqMan PCR). J Virol Methods 2000 85 : 75 82.
14. Martin P, Nash R, Sanders J, Leisenring W, Anasetti C, Deeg H-J, Storb R, Appelbaum F. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998 21 : 273 280.
15. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005 11 : 945.
16. Yeo W, Chan TC, Leung NWY, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009 27 : 605 611.
17. Lau GK, Leung YH, Fong DY, Au WY, Kwong YL, Lie A, Hou JL, Wen YM, Nanj A, Liang R. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood 2002 99 : 2324 2330.
18. Uhm JE, Kim K, Lim TK, et al. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007 13 : 463 468.
19. Tur-Kaspa R, Burk RD, Shaul Y, Shafritz DA. Hapatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci U S A 1986 83 : 1627 1631.
20. Loomba R, Rowley A, Wesley R, Liang TJ, Hoofmagle JH, Pucino F, Csako G. Systmetic review: The effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008 148 : 519 528.
21. Sherman M, Yurdydin C, Sallano J, et al. Entecavir for treatment of lamivudine-refractory. HBeAg-positive chronic hepatitis B. Gastroenterology 2006 130 : 2039 2049.
22. Colonno RJ, Rose R, Steven CJ, et al. Entecavir resistance is rare in nucleoside naïve patients with hepatitis B. Hepatlology 2006 44 : 1656 1665.
23. Colson P, Boretain P, Coso D, Chabannon C, Tamalet C, Gerolami R. Entecavir as a first-line treatment for HBV reactivation following polychemotherapy for lymphoma. Br J Haematol 2008 143 : 148 150.
24. Lazdina U, Alheim M, Nystöm J, et al. Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent. J Gen Virol 2003 84 : 139 146.
25. Ljungman P, Engelhard D, de la Cámara R, Einsele H, Locasciulli A, Martino R, Ribaud P, Ward K, Cordonnier C. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005 35 : 737 746.
26. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol 2007 136 : 699 712.